| Recruitment status | Main results already published |
| Unique ID issued by UMIN | UMIN000013859 |
| Receipt No. | R000016168 |
| Scientific Title | The TRAC-SI (Triage of Acute Chest pain using Speckle tracking Imaging) trial |
| Date of disclosure of the study information | 2014/05/01 |
| Last modified on | 2019/05/05 (Ver. 5) |
| Basic information | ||
| Public title | The TRAC-SI (Triage of Acute Chest pain using Speckle tracking Imaging) trial | |
| Acronym | The TRAC-SI trial | |
| Scientific Title | The TRAC-SI (Triage of Acute Chest pain using Speckle tracking Imaging) trial | |
| Scientific Title:Acronym | The TRAC-SI trial | |
| Region |
|
|
| Condition | ||
| Condition | Acute coronary syndrome | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To evaluate the usefulness of resting 2D speckle tracking echocardiography in the triage of patients with acute coronary syndrome (ACS) who visit the emergency department complaining of chest pain. (To determine whether strain analysis using 2D speckle tracking echocardiography improves the initial diagnosis of ACS in patients with chest pain who visit the emergency department.) |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Using the final diagnosis of ACS (truth standard) as the true value (sick or healthy), sensitivity is assessed for each of the three protocols: (1) combination of initial diagnosis and 2D speckle tracking echocardiography (Index + 2DST method), (2) initial diagnosis alone (Index method), and (3) 2D speckle tracking echocardiography alone (2DST method). |
| Key secondary outcomes | specificity, positive predictive value, and negative predictive value of above. |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients who visit the emergency department with a chief symptom of chest pain (newly onset, rest onset, and/or worsening) for 24 hours or less and are judged to meet all of the following conditions by the attending physician are enrolled in this trial.
1) Patients who are 20 years of age or older on the day informed consent is obtained (no upper age limit) 2) Patients with no significant ST elevation or abnormal Q waves on ECG 3) Patients with no systolic wall motion abnormalities |
|||
| Key exclusion criteria | Patients who meet any one of the following conditions are excluded from the trial.
1) Patients who show signs of moderate congestive heart failure (NYHA III or higher) 2) Patients who are in shock 3) Patients with LVEF less than 50% 4) Patients with left bundle branch block 5) Patients with a history of myocardial infarction or other myocardial disease 6) Patients with valvular heart disease for which invasive treatment is judged to be necessary 7) Patients in whom acceptable ultrasound images cannot be obtained 8) Patients who are found to have abnormal cardiac wall contraction by echocardiography 9) Patients with atrial fibrillation 10) Patients with a heart rate of 40 bpm or less or 100 bpm or higher 11) Patients with a serum creatinine level of 2.0 or higher 12) Patients with a history of allergy to contrast medium 13) Patients who are pregnant or breastfeeding, patients who may be pregnant 14) Patients who should be excluded from the trial for medical reasons, based on the judgment of their attending physician |
|||
| Target sample size | 403 | |||
| Research contact person | |||||||
| Last name of lead principal investigator |
|
||||||
| Organization | Kansai Electric Power Hospital | ||||||
| Division name | Department of Cardiology | ||||||
| Zip code | |||||||
| Address | 2-1-7 Fukushima, Fukushima-ku, Osaka-shi 553-0003 | ||||||
| TEL | 06-6458-5821 | ||||||
| ishii.katsuhisa@b2.kepco.co.jp | |||||||
| Public contact | |||||||
| 1st name of contact person |
|
||||||
| Organization | Nishinomiya Watanabe Cardiovascular Center | ||||||
| Division name | Division of Cardiology | ||||||
| Zip code | |||||||
| Address | 3-25, Ikedachyo, Nishinomiya City, Hyogo, Japan 662-0911 | ||||||
| TEL | 0798-36-1880 | ||||||
| Homepage URL | |||||||
| ehyodo47@gmail.com | |||||||
| Sponsor | |
| Institute | Department of Cardiology, Kansai Electric Power Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Toshiba Medical Systems |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | |
| Address | |
| Tel | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | Mayoクリニック Jae K. Oh
西宮渡辺心臓血管センター 吉川純一、兵頭永一 島根大学医学部附属病院 田邊一明 東京ベイ・浦安市川医療センター・ハートセンター 渡辺弘之 東京大学附属病院 大門雅夫、川田貴之 和歌山県立医科大学附属病院 赤阪隆史、田中篤、平田久美子 筑波大学附属病院 瀬尾由広、石津智子 東住吉森本病院 宮崎知奈美 東京医科大学附属病院 田中信大、武井康悦 手稲渓仁会病院 村上弘則 杏林大学医学部附属病院 坂田好美 九州大学医学部付属病院 有田武史 東京女子医科大学附属病院 新井光太郎 紀南病院 木村桂三 |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Main results already published | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Other | |
| Other related information | This is an open-label trial, but the analysis of images acquired using 2D speckle tracking echocardiography by the core laboratories should be conducted in a blinded manner.
1) Initial diagnosis ACS-positive patients should be defined based on the ECG and troponin values 1. Among the 16 left ventricular segments, 4 segments in the apical region and 6 segments in the basal region are excluded from analysis, and only the segments in the mid region are analyzed. The peak systolic strain value (%), time to peak strain, SIDI, and post systolic index are measured in each of the coronary artery territories (average of mid anterior septum and mid anterior wall for the anterior descending branch, mid inferior wall for the right coronary artery, and mid lateral wall for the circumflex branch). Apical-approach three-plane images are used for analysis of longitudinal strain, while short-axis images at the papillary muscle level are used for analysis of radial strain and circumferential strain. 2. Among the 16 left ventricular segments, 6 segments in the basal region are excluded from analysis, and only the segments in the apical and mid regions are analyzed. The peak systolic strain value (%), time to peak strain, SIDI, and post systolic index are measured in the territory of each coronary artery (average of apical and mid anterior septum and apical and mid anterior wall for the anterior descending branch, mid inferior wall for the right coronary artery, and mid lateral wall for the circumflex branch). Apical-approach three-plane images are used for analysis of longitudinal strain, while short-axis images at the papillary muscle level are used for analysis of radial strain and circumferential strain. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000016168 |